Small cap movers: Sun shines on Ncondezi Energy Ltd proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
The biggest small-cap riser this week was Trafalgar Property Group and we d love to be able to tell you why but if the company does not know, what chance do we have?
Written by Robby Berman on April 22, 2021 Fact checked by Rita Ponce, Ph.D.
Scientists are planning a trial that will determine whether or not people who have had COVID-19 are now immune to the virus that causes it. STEVE PARSONS/Getty Images
Experts still have a lot to learn about the likelihood that people who have had COVID-19 can contract SARS-CoV-2 again.
Scientists at the University of Oxford in the United Kingdom have announced a human challenge trial to gather hard, precise data that will provide a better understanding of how reinfection works.
Under carefully controlled conditions and for research purposes, scientists will reinfect the participants in the study with the original SARS-CoV-2 variant.
Share This
The FINANCIAL Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time, Oxford University notes.
Researchers at the University of Oxford have launched a human challenge trial to look at what kind of immune response can stop people from becoming re-infected. They also want to see how the immune system reacts second time round. A human challenge trial in medical research is a carefully controlled study that involves purposefully infecting a subject with a pathogen or bug, in order to study the effects of that infection.